CN104911104B - In-vitro cell and organ 3-D culture device and artificial organ culture method - Google Patents
In-vitro cell and organ 3-D culture device and artificial organ culture method Download PDFInfo
- Publication number
- CN104911104B CN104911104B CN201510346955.7A CN201510346955A CN104911104B CN 104911104 B CN104911104 B CN 104911104B CN 201510346955 A CN201510346955 A CN 201510346955A CN 104911104 B CN104911104 B CN 104911104B
- Authority
- CN
- China
- Prior art keywords
- culture
- vitro
- cells
- longitudinal
- organs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000000056 organ Anatomy 0.000 title claims abstract description 61
- 238000000338 in vitro Methods 0.000 title claims abstract description 45
- 238000012136 culture method Methods 0.000 title description 3
- 230000033001 locomotion Effects 0.000 claims abstract description 57
- 230000007246 mechanism Effects 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 27
- 230000012010 growth Effects 0.000 claims abstract description 20
- 238000011161 development Methods 0.000 claims abstract description 14
- 210000004185 liver Anatomy 0.000 claims description 21
- 239000012531 culture fluid Substances 0.000 claims description 10
- 238000005096 rolling process Methods 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- 230000001143 conditioned effect Effects 0.000 claims description 3
- 239000013013 elastic material Substances 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 230000007613 environmental effect Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 34
- 210000000130 stem cell Anatomy 0.000 abstract description 15
- 210000003754 fetus Anatomy 0.000 abstract description 5
- 210000005260 human cell Anatomy 0.000 abstract description 4
- 230000004069 differentiation Effects 0.000 abstract description 3
- 238000002474 experimental method Methods 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract 1
- 239000007789 gas Substances 0.000 description 25
- 239000000243 solution Substances 0.000 description 18
- 239000002609 medium Substances 0.000 description 17
- 230000018109 developmental process Effects 0.000 description 10
- 230000006872 improvement Effects 0.000 description 10
- 210000002826 placenta Anatomy 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 210000004381 amniotic fluid Anatomy 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 6
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 5
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 5
- WSNMPAVSZJSIMT-UHFFFAOYSA-N COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 Chemical compound COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 WSNMPAVSZJSIMT-UHFFFAOYSA-N 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 101001011741 Bos taurus Insulin Proteins 0.000 description 3
- 101000766306 Homo sapiens Serotransferrin Proteins 0.000 description 3
- XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 description 3
- 102000004140 Oncostatin M Human genes 0.000 description 3
- 108090000630 Oncostatin M Proteins 0.000 description 3
- 239000005700 Putrescine Substances 0.000 description 3
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 3
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- IXIBAKNTJSCKJM-BUBXBXGNSA-N bovine insulin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 IXIBAKNTJSCKJM-BUBXBXGNSA-N 0.000 description 3
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 3
- 229960003957 dexamethasone Drugs 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 229950008325 levothyroxine Drugs 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 229960003387 progesterone Drugs 0.000 description 3
- 239000000186 progesterone Substances 0.000 description 3
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 3
- 206010058314 Dysplasia Diseases 0.000 description 2
- 101000898034 Homo sapiens Hepatocyte growth factor Proteins 0.000 description 2
- 101001076408 Homo sapiens Interleukin-6 Proteins 0.000 description 2
- 101000868152 Homo sapiens Son of sevenless homolog 1 Proteins 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000003636 conditioned culture medium Substances 0.000 description 2
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 230000031142 liver development Effects 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 229960001471 sodium selenite Drugs 0.000 description 2
- 235000015921 sodium selenite Nutrition 0.000 description 2
- 239000011781 sodium selenite Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 208000022752 well-differentiated liposarcoma Diseases 0.000 description 2
- 238000012604 3D cell culture Methods 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102100021866 Hepatocyte growth factor Human genes 0.000 description 1
- WQZGKKKJIJFFOK-ZZWDRFIYSA-N L-glucose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-ZZWDRFIYSA-N 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 101150052863 THY1 gene Proteins 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000001136 chorion Anatomy 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- XPXMKIXDFWLRAA-UHFFFAOYSA-N hydrazinide Chemical compound [NH-]N XPXMKIXDFWLRAA-UHFFFAOYSA-N 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 230000021368 organ growth Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 229940082569 selenite Drugs 0.000 description 1
- MCAHWIHFGHIESP-UHFFFAOYSA-L selenite(2-) Chemical compound [O-][Se]([O-])=O MCAHWIHFGHIESP-UHFFFAOYSA-L 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/08—Bioreactors or fermenters specially adapted for specific uses for producing artificial tissue or for ex-vivo cultivation of tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/38—Caps; Covers; Plugs; Pouring means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/48—Holding appliances; Racks; Supports
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M27/00—Means for mixing, agitating or circulating fluids in the vessel
- C12M27/10—Rotating vessel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/42—Means for regulation, monitoring, measurement or control, e.g. flow regulation of agitation speed
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/48—Automatic or computerized control
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- C12N5/0671—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2513/00—3D culture
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Sustainable Development (AREA)
- Analytical Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Computer Hardware Design (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
本发明公开了一种细胞及器官体外3‑D培养装置及人工器官培育的方法,涉及微生物学技术领域,该装置包括培养室、3‑D运动摇箱,以及分别与培养室连通的条件培养液循环系统和气体交换系统,还包括多自由度运动机构。该方法包括利用细胞及器官体外3‑D培养装置模拟人体器官生长发育的动态环境培育人工器官。本发明通过设置3‑D运动摇箱较真实的模拟了人体细胞或器官在母体内发育胎儿的生长微环境,提高各种子干细胞在体外3‑D培养中生长和分化为功能性细胞的效率,为细胞体外3‑D培养提供一个简单、经济、温和、立体、营养全面的生长微环境,实验表明采用本装置进行人体器官体外培育的方法是可行的,可以进行临床推广应用。
The invention discloses a 3-D culture device in vitro for cells and organs and a method for cultivating artificial organs, and relates to the technical field of microbiology. The liquid circulation system and the gas exchange system also include a multi-degree-of-freedom motion mechanism. The method comprises using a 3-D culture device in vitro of cells and organs to simulate the dynamic environment of growth and development of human organs to cultivate artificial organs. The present invention more realistically simulates the growth microenvironment of human cells or organs developing fetus in the mother by setting a 3-D motion shaker, and improves the growth and differentiation efficiency of various stem cells into functional cells in 3-D culture in vitro , to provide a simple, economical, mild, three-dimensional, and nutritionally comprehensive growth microenvironment for 3-D culture of cells in vitro. Experiments show that the method of using this device for in vitro cultivation of human organs is feasible and can be applied clinically.
Description
技术领域technical field
本发明属于微生物学技术领域,涉及一种细胞及器官体外3-D培养装置及人工器官的培育方法。The invention belongs to the technical field of microbiology, and relates to an in vitro 3-D culture device for cells and organs and a cultivation method for artificial organs.
背景技术Background technique
为避免细胞或组织在二维(2-D)生长过程中逐渐失去许多原组织生理特征的弊端,人们发明了体外三维(3-D)培养。目前采用的体外3-D培养装置主要采用生物反应器(Bioreactor,BR),是指利用酶或生物体(如微生物)所具有的生物功能在体外提供生物活性环境的装置系统或工程设备。根据培养细胞、培养载体、培养液混合方式的不同BR主要分为搅拌式、气体式、中空纤维式、回旋式(空间BR)等。根据结构的不同BR分为旋转技术结合普通37℃ 5%CO2细胞培养箱的箱体结构;循环培养装置和普通37℃ 5%CO2细胞培养箱的箱体结构、循环培养装置和普通37℃ 5%CO2细胞培养箱各自独立装置和循环培养结合气体交换密闭式装置。此外,与BR配套的辅助技术还有灌注培养式、微载体式、多孔微球式等。In order to avoid the drawbacks of cells or tissues gradually losing many physiological characteristics of the original tissue during two-dimensional (2-D) growth, in vitro three-dimensional (3-D) culture was invented. Currently used in vitro 3-D culture devices mainly use bioreactor (Bioreactor, BR), which refers to a device system or engineering equipment that uses the biological functions of enzymes or organisms (such as microorganisms) to provide a biologically active environment in vitro. According to the different mixing methods of cultured cells, culture carriers, and culture medium, BR is mainly divided into stirring type, gas type, hollow fiber type, and rotary type (space BR). According to different structures, BR is divided into the box structure of rotating technology combined with ordinary 37°C 5% CO2 cell incubator; the box structure of circulating culture device and ordinary 37°C 5% CO2 cell incubator, circulating culture device and ordinary 37°C 5 The %CO2 cell incubator is an independent device and a closed device for circulating culture combined with gas exchange. In addition, the supporting technologies for BR include perfusion culture, microcarrier, porous microsphere, etc.
然而,从经济效益考虑,这些BR普遍存在成本高、设备复杂等。例如从功能角度搅拌式BR的搅拌桨叶产生的剪切力可对细胞造成损伤;中空纤维式BR的培养环境不均一、培养工艺不易放大、消毒重复使用困难等;从结构角度分析,结构一装置造价昂贵,体积庞大,无疑增加了对仪器购买及使用的难度;结构二装置除造价昂贵,体积庞大外,装置中3-D培养管是固定存在培养箱中的,不能进行旋转,无法很好实现细胞或组织类似于人体发育过程这样一个自然悬空运动生长的立体培养功能,导致人工器官功能缺失或发育不良;结构三装置中虽然摇摆或旋转系统可使细胞3-D培养在动态过程中,但由于3-D培养管置于培养箱外,大大增加了污染机率,循环培养结合气体交换密闭式装置则要求造价较高的高级别周围培养氛围。However, from the perspective of economic benefits, these BRs generally have high cost and complicated equipment. For example, from the functional point of view, the shear force generated by the stirring blades of the stirring BR can cause damage to the cells; the cultivation environment of the hollow fiber BR is not uniform, the cultivation process is not easy to scale up, and it is difficult to sterilize and reuse; from the structural point of view, the structural one The device is expensive and bulky, which undoubtedly increases the difficulty of purchasing and using the instrument; the structure 2 device is expensive and bulky, and the 3-D culture tube in the device is fixed in the incubator and cannot be rotated, so it cannot be quickly It is good to realize the three-dimensional culture function of cells or tissues growing in a natural suspension movement similar to the human body development process, resulting in the loss of function or dysplasia of artificial organs; although the swing or rotation system in the three-structure device can make cells 3-D culture in a dynamic process , but because the 3-D culture tube is placed outside the incubator, the probability of contamination is greatly increased, and the circulation culture combined with the gas exchange closed device requires a high-level surrounding culture atmosphere with high cost.
为克服上述问题,急需对现有的培养装置进行结构改进,改进的装置既可模拟胎儿在母体胎盘羊水发育过程中的复合运动,又可进行代谢物质的循环交换,既可充分满足细胞高密度增值需要,又可保证细胞高效分泌,为细胞或器官体外培育提供一个简单、经济、温和、立体、营养全面的3-D生长微环境,促进细胞再生和人工器官的生成。In order to overcome the above problems, there is an urgent need to improve the structure of the existing culture device. The improved device can not only simulate the compound movement of the fetus during the development of amniotic fluid in the placenta of the mother, but also carry out the cyclic exchange of metabolites, which can fully meet the needs of high-density cells. Value-added needs, but also to ensure efficient secretion of cells, to provide a simple, economical, gentle, three-dimensional, nutritionally comprehensive 3-D growth microenvironment for in vitro cultivation of cells or organs, and to promote cell regeneration and the generation of artificial organs.
发明内容Contents of the invention
有鉴于此,本发明的目的之一是提供一种细胞及器官体外3-D培养装置,以解决现有技术无法真实模拟人体器官生长微环境导致人工器官存在发育不良、功能缺失、培育效率低的问题。本发明的目的之二提供采用上述细胞及器官体外3-D培养装置进行人工培育器官的方法。In view of this, one of the purposes of the present invention is to provide an in vitro 3-D culture device for cells and organs to solve the problem that existing technologies cannot truly simulate the growth microenvironment of human organs, resulting in dysplasia, loss of function, and low cultivation efficiency of artificial organs. The problem. The second object of the present invention is to provide a method for artificially cultivating organs using the above-mentioned in vitro 3-D culture device for cells and organs.
本发明的目的之一是通过以下技术方案实现的:One of purpose of the present invention is achieved through the following technical solutions:
本发明的细胞及器官体外3-D培养装置,包括培养室、可做复合运动的3-D运动摇箱,以及分别与培养室连通的条件培养液循环系统和气体交换系统,所述培养室通过弹性部件可拆卸的悬挂于3-D运动摇箱内,还包括设置在3-D运动摇箱一侧或两侧的多自由度运动机构。The 3-D culture device for cells and organs in vitro of the present invention comprises a culture room, a 3-D motion shaking box capable of compound motion, and a conditional culture solution circulation system and a gas exchange system respectively communicated with the culture room. It is detachably suspended in the 3-D motion shaker through elastic components, and also includes a multi-degree-of-freedom motion mechanism arranged on one side or both sides of the 3-D motion shaker.
进一步,所述培养室的培养环境:温度为37℃;湿度为95~98%;含体积分数为5%CO2的空气;酸碱p H值为7.2-7.4。Further, the culture environment of the culture room: the temperature is 37°C; the humidity is 95-98%; the air contains 5% CO 2 by volume; the pH value of the acid-base is 7.2-7.4.
进一步,所述多自由度运动机构包括纵向旋转机构、水平旋转机构和设置在两者之间的多功能连接结构,所述条件培养液循环系统及气体交换系统通过多功能连接结构与外界连接进行培养液及气体交换。Further, the multi-degree-of-freedom motion mechanism includes a longitudinal rotation mechanism, a horizontal rotation mechanism, and a multifunctional connection structure arranged between the two, and the conditional culture fluid circulation system and the gas exchange system are connected to the outside world through the multifunctional connection structure. Culture medium and gas exchange.
进一步,所述纵向旋转机构包括纵向旋转轴和调速电机I,所述纵向旋转轴的一端与3-D运动摇箱固定,另一端与调速电机I的主轴固定。Further, the longitudinal rotation mechanism includes a longitudinal rotation shaft and a speed-regulating motor 1, one end of the longitudinal rotation shaft is fixed with the 3-D motion shaker, and the other end is fixed with the main shaft of the speed-regulation motor 1.
进一步,所述水平旋转机构包括水平旋转架、水平旋转轴和调速电机II,所述水平旋转架的一端与纵向旋转轴的一端转动连接,另一端与水平旋转轴的一端转动连接,所述水平旋转轴的另一端与调速电机II的主轴固定。Further, the horizontal rotation mechanism includes a horizontal rotation frame, a horizontal rotation shaft and a speed-regulating motor II, one end of the horizontal rotation frame is rotatably connected to one end of the longitudinal rotation shaft, and the other end is rotatable connection to one end of the horizontal rotation shaft. The other end of the horizontal rotating shaft is fixed with the main shaft of the speed-regulating motor II.
进一步,所述水平旋转架与纵向及水平旋转轴的连接处均设置有多功能连接结构。Further, the joints between the horizontal rotating frame and the longitudinal and horizontal rotating shafts are provided with multifunctional connecting structures.
进一步,所述多自由度运动机构设置在3-D运动摇箱的两侧,所述多自由度运动机构还包括固定设置在3-D运动摇箱另一侧的纵向从动轴,所述纵向从动轴与水平旋转架之间设置有多功能连接结构。Further, the multi-degree-of-freedom motion mechanism is arranged on both sides of the 3-D motion shaker, and the multi-degree-of-freedom motion mechanism also includes a longitudinal driven shaft fixedly arranged on the other side of the 3-D motion shaker, the A multifunctional connecting structure is arranged between the longitudinal driven shaft and the horizontal rotating frame.
进一步,所述多功能连接结构包括可转动且密封套装于纵向或水平旋转轴外圆面的活动套、设置在活动套与纵向或水平旋转轴之间的密封腔、设置在活动套与纵向或水平旋转轴之间的滚动轴承,以及设置在水平旋转轴、水平旋转架、纵向旋转轴和纵向从动轴内的条件培养液循环通道和气体交换通道,所述密封腔通过条件培养液循环通道及气体交换通道分别与培养室连通。Further, the multifunctional connection structure includes a movable sleeve that is rotatable and hermetically fitted on the outer surface of the longitudinal or horizontal rotating shaft, a sealing chamber arranged between the movable sleeve and the longitudinal or horizontal rotating shaft, and a sealing chamber arranged between the movable sleeve and the longitudinal or horizontal rotating shaft. The rolling bearings between the horizontal rotation shafts, and the conditional culture solution circulation channel and gas exchange channel arranged in the horizontal rotation shaft, horizontal rotation frame, longitudinal rotation shaft and longitudinal driven shaft, the sealed cavity passes through the conditional culture solution circulation channel and The gas exchange channels communicate with the culture chambers respectively.
进一步,所述培养室内均匀间隔设置有多个弹性材料制成的挡板,所述挡板的头部设置具有圆弧顶部的弹性缓冲薄膜。Further, a plurality of baffles made of elastic material are evenly spaced in the cultivation chamber, and elastic buffer films with arc tops are provided on the heads of the baffles.
进一步,所述弹性部件为弹簧或橡胶或其它弹性件。Further, the elastic component is a spring or rubber or other elastic components.
进一步,所述培养室包括室体和可将室体密封固定的室盖,所述室盖设置有与室体相互嵌合的卡合结构,所述室体设置有与卡合结构相匹配的卡合配合结构。Further, the culture chamber includes a chamber body and a chamber cover that can seal and fix the chamber body, the chamber cover is provided with a locking structure that fits with the chamber body, and the chamber body is provided with a matching structure. Snap fit construction.
进一步,还包括用于对本培养装置进行全自动控制的PLC控制系统和信息显示系统。Further, it also includes a PLC control system and an information display system for fully automatic control of the cultivation device.
本发明的目的之二是通过以下技术方案实现的:Two of the purpose of the present invention is achieved through the following technical solutions:
采用如上所述体外细胞及器官3-D培养装置培育人工器官的方法,利用细胞及器官体外3-D培养装置模拟人体器官生长发育的动态环境培育人工器官。Using the method for cultivating artificial organs with the above-mentioned in vitro cell and organ 3-D culture device, the artificial organ is cultivated by using the cell and organ in vitro 3-D culture device to simulate the dynamic environment of human organ growth and development.
进一步,所述人体器官生长发育的动态环境包括:将种子细胞的天然去细胞的整体器官支架弹性地悬挂于3-D培养装置内,在37℃、体积分数为5%CO2条件下分阶段培养,第一阶段1~7天,第二阶段8~14天,第三阶段15~21天,采用24h动态培养,白天先水平向左360°旋转,后水平向右360°旋转,晚上采用纵向旋转和水平旋转相结合的复合3-D旋转,白天转速为20~40rpm/min,晚上转速小于20rpm/min,每三天换培养基一次,每阶段更换不同的培养基。Further, the dynamic environment for the growth and development of human organs includes: elastically suspending the natural decellularized whole organ scaffold of the seed cells in a 3-D culture device, and stage-by-stage at 37°C and 5% CO 2 Cultivation, the first stage is 1-7 days, the second stage is 8-14 days, and the third stage is 15-21 days. 24h dynamic culture is adopted. During the day, it first rotates 360° to the left horizontally, and then rotates 360° to the right horizontally. The composite 3-D rotation combining vertical rotation and horizontal rotation, the rotation speed is 20-40rpm/min during the day, and the rotation speed is less than 20rpm/min at night, the medium is changed every three days, and different mediums are replaced at each stage.
本发明的有益效果:Beneficial effects of the present invention:
1、本发明的的细胞及器官体外3-D培养装置,通过设置3-D运动摇箱模拟胎儿在母体胎盘羊水发育过程中的人体发育复合运动,并通过培养室弹性的设置在摇箱内模拟培养物在人体内悬吊过程中的简谐运动,较真实的模拟了人体细胞或器官在发育过程中的生长微环境,提高各种种子细胞的分化为成熟细胞密度及培养效率,为细胞或器官的体外3-D培养提供一个简单、经济、温和、立体、营养全面的生长微环境,加速体外人工器官生成,该装置与现有技术相比,具有明显的成本优势和推广价值。1. The 3-D culture device for cells and organs in vitro of the present invention simulates the compound movement of human body development of the fetus in the process of amniotic fluid development of the mother's placenta by setting a 3-D motion shaker, and is elastically arranged in the shaker by the culture chamber Simulate the simple harmonic motion of the culture during the suspension process in the human body, more realistically simulate the growth microenvironment of human cells or organs during the development process, improve the differentiation of various seed cells into mature cell density and culture efficiency, and provide cells Or the in vitro 3-D culture of organs provides a simple, economical, mild, three-dimensional, nutritionally comprehensive growth microenvironment to accelerate the generation of in vitro artificial organs. Compared with the existing technology, this device has obvious cost advantages and promotion value.
2、通过多功能连接结构实现介质输入系统与转轴之间可相对转动的目的,再由于将各介质通道设置在转轴上,3-D运动摇箱与培养室实现生长环境所需介质(培养液及37℃5%CO2气体)与培养室连通和交换,解决了多自由度转动过程中输入管道缠绕的问题。2. Through the multifunctional connection structure, the purpose of relative rotation between the medium input system and the rotating shaft can be realized, and since each medium channel is set on the rotating shaft, the 3-D motion shaker and the culture room can realize the medium (culture solution) required for the growth environment. and 37°C 5% CO 2 gas) are communicated and exchanged with the cultivation chamber, which solves the problem of input pipeline winding during multi-degree-of-freedom rotation.
3、本发明培育人工器官的方法,由于该装置真实模拟人体细胞或器官的生长发育微环境,可以实现对各种人体器官的体外培育和重建。利用本发明的方法培养形成的肝脏样组织仅需3周时间,比近期报道采用BR方法体外诱导DLS间充质干细胞(Meschymal stemcells,MSC)形成的肝样组织(需要4周时间)节省1周时间,实验表明本发明制得的人工肝脏具有肝脏结构和功能,能够作为肝移植供体使用,进一步证实采用本装置进行人体器官体外培育的方法是可行的,可以进行临床推广应用,且具有广阔的应用前景和较高的社会价值。3. The method for cultivating artificial organs of the present invention can realize in vitro cultivation and reconstruction of various human organs because the device truly simulates the growth and development microenvironment of human cells or organs. It takes only 3 weeks to culture the liver-like tissue formed by the method of the present invention, which is 1 week less than the liver-like tissue (requiring 4 weeks) induced by the BR method in vitro to form the liver-like tissue formed by DLS mesenchymal stem cells (MSCs) in vitro. Time, experiments show that the artificial liver prepared by the present invention has liver structure and function, and can be used as a liver transplantation donor. It is further confirmed that the method of using this device for in vitro cultivation of human organs is feasible and can be applied clinically, and has a wide range of applications. application prospects and high social value.
本发明的其他优点、目标和特征在某种程度上将在随后的说明书中进行阐述,并且在某种程度上,基于对下文的考察研究对本领域技术人员而言将是显而易见的,或者可以从本发明的实践中得到教导。本发明的目标和其他优点可以通过下面的说明书来实现和获得。Other advantages, objects and features of the present invention will be set forth in the following description to some extent, and to some extent, will be obvious to those skilled in the art based on the investigation and research below, or can be obtained from It is taught in the practice of the present invention. The objects and other advantages of the invention may be realized and attained by the following specification.
附图说明Description of drawings
为了使本发明的目的、技术方案和优点更加清楚,下面将结合附图对本发明作进一步的详细描述,其中:In order to make the purpose, technical solutions and advantages of the present invention clearer, the present invention will be described in further detail below in conjunction with the accompanying drawings, wherein:
附图1为本发明的体外细胞及器官3-D培养装置的结构示意图;Accompanying drawing 1 is the structural representation of the in vitro cell and organ 3-D culture device of the present invention;
附图2为本发明培养室的放大图;Accompanying drawing 2 is the enlargement figure of cultivation room of the present invention;
附图3为本发明多功能连接结构I的放大图;Accompanying drawing 3 is the enlarged view of multifunctional connecting structure I of the present invention;
附图4为本发明多功能连接结构II的放大图;Accompanying drawing 4 is the enlarged view of multifunctional connecting structure II of the present invention;
附图5为本发明多功能连接结构III的放大图。Accompanying drawing 5 is the enlarged view of the multifunctional connecting structure III of the present invention.
附图6为用本装置培育的人工肝脏。A为体外3-D培养第9天生成肝叶样结构;B体外3-D培养第21天生成类全肝样结构;C(a-b)组织切片显示有与正常肝脏相似的肝小叶样结构;C(c)分泌肝功能蛋白。Accompanying drawing 6 is the artificial liver cultivated with this device. A: Hepatic lobe-like structures formed on the 9th day of in vitro 3-D culture; B: Whole liver-like structures were formed on the 21st day of in vitro 3-D culture; C(a-b) tissue sections showed hepatic lobule-like structures similar to normal liver; C(c) secretes liver function proteins.
附图7为为哺乳类动物肝脏发育成熟示意图。A为小鼠;B为人类。Accompanying drawing 7 is the schematic diagram of mammalian liver development and maturation. A is mouse; B is human.
附图标记:1-培养室;2-3-D运动摇箱;3-纵向旋转轴;4-调速电机I;5-水平旋转架;6-水平旋转轴;7-调速电机II;8-纵向从动轴;9-活动套;10-滚动轴承;11-培养液循环通道;12-气体交换通道;13-密封腔I;14-密封腔II;15-密封腔III;16-密封腔IV;17-培养液管;18-气管;19-挡板;20-弹性缓冲薄膜;21-培养物;22-弹簧;23-室体;24-室盖;25-凸起;26-开口槽;27-驱动泵;28-PLC控制系统;29-信息显示系统;30-多功能连接结构I;31-多功能连接结构II;32-多功能连接结构III。Reference signs: 1-cultivation room; 2-3-D motion shaking box; 3-longitudinal rotation shaft; 4-speed regulating motor I; 5-horizontal rotating frame; 6-horizontal rotating shaft; 7-speed regulating motor II; 8-longitudinal driven shaft; 9-movable sleeve; 10-rolling bearing; 11-culture solution circulation channel; 12-gas exchange channel; 13-seal chamber I; 14-seal chamber II; 15-seal chamber III; 16-seal Chamber IV; 17-culture solution tube; 18-trachea; 19-baffle; 20-elastic buffer film; 21-culture; 22-spring; 23-chamber body; 24-chamber cover; Open slot; 27-drive pump; 28-PLC control system; 29-information display system; 30-multifunctional connection structure I; 31-multifunctional connection structure II; 32-multifunctional connection structure III.
具体实施方式detailed description
以下将参照附图,对本发明的优选实施例进行详细的描述。应当理解,优选实施例仅为了说明本发明,而不是为了限制本发明的保护范围。Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings. It should be understood that the preferred embodiments are only for illustrating the present invention, but not for limiting the protection scope of the present invention.
实施例1、体外细胞及器官3-D培养装置Embodiment 1, in vitro cell and organ 3-D culture device
如图1-5所示,包括培养室1、3-D运动摇箱2,以及分别与培养室1连通的培养液交换系统和气体交换系统,所述培养室1内可模拟胎儿在母体胎盘羊水中发育生长环境,包括与人体胎盘相适应的温度环境、氧气环境及各种复杂运动的动态环境,用培养室1模拟胎盘,用培养液模拟母体胎盘中的羊水,用气体交换系统实现温度环境、氧气环境,用3-D运动摇箱2模拟胎儿在母体胎盘羊水发育过程中的人体复合运动,最终实现的培育环境:温度为37℃;湿度为95~98%;含体积分数为5%CO2的空气;酸碱p H值为7.2-7.4;包括将培养室1通过弹性部件可灵活拆卸的固定于3-D运动摇箱2内,作各种不规则运动,实现的动态环境。As shown in Figures 1-5, it includes a culture room 1, a 3-D motion shaker 2, and a culture fluid exchange system and a gas exchange system that are respectively connected to the culture room 1. Amniotic fluid development and growth environment, including the temperature environment, oxygen environment and dynamic environment of various complex movements that are compatible with the human placenta. The culture room 1 is used to simulate the placenta, the culture medium is used to simulate the amniotic fluid in the mother's placenta, and the gas exchange system is used to realize the temperature. Environment, oxygen environment, using 3-D motion shaker 2 to simulate the human compound movement of the fetus in the process of amniotic fluid development in the mother's placenta, and finally realized the cultivation environment: the temperature is 37°C; the humidity is 95-98%; the volume fraction is 5 Air with % CO 2 ; acid-base pH value is 7.2-7.4; including fixing the culture chamber 1 in the 3-D motion shaking box 2 through elastic parts which can be flexibly disassembled, and performing various irregular movements to realize a dynamic environment .
本实施例通过设置3-D运动摇箱模拟胎儿在母体胎盘羊水发育过程中的人体复合运动,并通过培养室弹性的设置在摇箱内模拟器官在人体内的悬吊过程中的简谐运动,较真实的模拟了人体细胞或器官在人体内真实的生长环境,提高各种种子干细胞的分化为成熟细胞密度水平和有效促进3-D细胞培养效率,为体外器官的生长提供一个简单、经济、温和、立体、营养全面的生长环境,加速细胞再生和器官形成,该装置与现有技术相比,具有明显的成本优势和推广价值。In this embodiment, a 3-D motion shaking box is set to simulate the compound movement of the human body during the development of the fetus in the mother's placenta and amniotic fluid, and the simple harmonic motion of the suspension of the organs in the human body is simulated by elastically setting the training room in the shaking box , more realistically simulates the real growth environment of human cells or organs in the human body, improves the differentiation of various seed stem cells into mature cell density levels and effectively promotes the efficiency of 3-D cell culture, and provides a simple and economical method for the growth of in vitro organs , mild, three-dimensional, nutritionally comprehensive growth environment, accelerate cell regeneration and organ formation, compared with the prior art, the device has obvious cost advantages and popularization value.
作为本实施例的改进,还包括设置在3-D运动摇箱一侧或两侧的多自由度运动机构,本实施例设置在3-D运动摇箱2的两侧,所述多自由度运动机构包括纵向旋转机构、水平旋转机构和设置在两者之间的多功能连接结构,实现3-D运动摇箱2的水平和纵向方向的旋转,所述培养液交换系统及气体交换系统通过多功能连接结构与外界连接交换,实现与外界37℃5%CO2气体交换和培养液的交换,达到细胞和器官生长相适宜的温度环境、氧气环境及羊水环境。As an improvement of this embodiment, it also includes a multi-degree-of-freedom motion mechanism arranged on one side or both sides of the 3-D motion shaker. This embodiment is arranged on both sides of the 3-D motion shaker 2. The multi-degree-of-freedom The motion mechanism includes a vertical rotation mechanism, a horizontal rotation mechanism and a multifunctional connection structure arranged between them to realize the horizontal and vertical rotation of the 3-D motion shaking box 2. The culture fluid exchange system and the gas exchange system pass through The multi-functional connection structure is connected and exchanged with the outside world to realize the gas exchange with the outside world at 37°C 5% CO 2 and the exchange of the culture medium, so as to achieve the temperature environment, oxygen environment and amniotic fluid environment suitable for the growth of cells and organs.
作为本实施例的改进,所述纵向旋转机构包括纵向旋转轴3和调速电机I 4,所述纵向旋转轴3的一端与3-D运动摇箱2固定,另一端与调速电机I 4的主轴固定,在调速电机I4的驱动下,使3-D运动摇箱2产生纵向方向的左、右旋转转动。As an improvement of this embodiment, the longitudinal rotation mechanism includes a longitudinal rotation shaft 3 and a speed-regulating motor 14, one end of the longitudinal rotation shaft 3 is fixed to the 3-D motion shaking box 2, and the other end is connected to the speed-regulating motor 14 The main shaft is fixed, and driven by the speed-regulating motor I4, the 3-D motion shaking box 2 is rotated left and right in the longitudinal direction.
作为本实施例的改进,所述水平旋转机构包括水平旋转架5、水平旋转轴6和调速电机II 7,所述水平旋转架5的一端与纵向旋转轴3的一端转动连接,另一端与水平旋转轴6的一端转动连接,所述水平旋转轴6的另一端与调速电机II 7的主轴固定,在调速电机II 7的驱动下,驱动水平旋转轴6及水平旋转架5转动,最终驱使3-D运动摇箱2产生水平方向的左、右旋转转动。As an improvement of this embodiment, the horizontal rotation mechanism includes a horizontal rotation frame 5, a horizontal rotation shaft 6 and a speed regulating motor II 7, one end of the horizontal rotation frame 5 is rotationally connected with one end of the longitudinal rotation shaft 3, and the other end is connected with the vertical rotation shaft 3. One end of the horizontal rotating shaft 6 is rotationally connected, and the other end of the horizontal rotating shaft 6 is fixed to the main shaft of the speed-regulating motor II 7. Driven by the speed-regulating motor II 7, the horizontal rotating shaft 6 and the horizontal rotating frame 5 are driven to rotate. Finally, the 3-D motion shaker 2 is driven to rotate left and right in the horizontal direction.
作为本实施例的改进,所述多自由度运动机构还包括固定设置在3-D运动摇箱2另一侧的纵向从动轴8,所述纵向从动轴8与水平旋转架5之间设置有多功能连接结构I 30,所述水平旋转架5与纵向旋转轴3的连接处设置有多功能连接结构II 31,水平旋转架5与水平旋转轴6的连接处设置有多功能连接结构III 32,所述多功能连接结构包括可转动且密封套装于纵向旋转轴3或水平旋转轴6外圆面的活动套9、设置在活动套9与纵向旋转轴3或水平旋转轴6之间的密封腔、设置在活动套9与纵向旋转轴3或水平旋转轴6之间的滚动轴承10,以及设置在水平旋转轴6、水平旋转架6、纵向旋转轴3和纵向从动轴8内的培养液循环通道11和气体交换通道12,所述密封腔通过与培养液循环通道11和气体交换通道12分别与培养室1连通,所述密封腔设置为环形结构,多功能连接结构III 32具有两个相互独立的密封腔I、II(13、14),多功能连接结构I 30具有一个密封腔III 15,多功能连接结构II 31具有一个密封腔IV 16,所述培养液交换系统包括依次连通的密封腔I 13、水平旋转轴及水平旋转架部分的培养液循环通道11、密封腔III 15、纵向从动轴部分的培养液循环通道11、与培养液循环通道连通的培养液管17,所述密封腔I 13与外界培养液源连通,所述培养液管17穿过3-D运动摇箱2与培养室1连通;所述气体交换系统包括依次连通的密封腔II 14、水平旋转轴及水平旋转架部分的气体交换通道12、密封腔IV 16、纵向旋转轴部分的气体交换通道12、与气体交换通道12连通的气管18,所述密封腔II 14与外界37℃ 5%CO2气源连通,所述气管18穿过3-D运动摇箱2与培养室1连通。As an improvement of this embodiment, the multi-degree-of-freedom motion mechanism also includes a longitudinal driven shaft 8 fixedly arranged on the other side of the 3-D motion shaker 2, between the longitudinal driven shaft 8 and the horizontal rotating frame 5 A multifunctional connection structure I 30 is provided, a multifunctional connection structure II 31 is provided at the connection between the horizontal rotation frame 5 and the longitudinal rotation shaft 3, and a multifunctional connection structure is provided at the connection between the horizontal rotation frame 5 and the horizontal rotation shaft 6 III 32, the multifunctional connection structure includes a movable sleeve 9 that is rotatable and hermetically sleeved on the outer surface of the longitudinal rotation shaft 3 or the horizontal rotation shaft 6, and is arranged between the movable sleeve 9 and the longitudinal rotation shaft 3 or the horizontal rotation shaft 6 The sealing cavity, the rolling bearing 10 arranged between the movable sleeve 9 and the longitudinal rotating shaft 3 or the horizontal rotating shaft 6, and the rolling bearings 10 arranged in the horizontal rotating shaft 6, the horizontal rotating frame 6, the longitudinal rotating shaft 3 and the longitudinal driven shaft 8 The culture fluid circulation channel 11 and the gas exchange channel 12, the sealed cavity communicates with the culture chamber 1 through the culture fluid circulation channel 11 and the gas exchange channel 12 respectively, the sealed cavity is arranged in an annular structure, and the multifunctional connecting structure III 32 has Two mutually independent sealed chambers I, II (13, 14), the multifunctional connecting structure I 30 has a sealed chamber III 15, the multifunctional connecting structure II 31 has a sealed chamber IV 16, and the culture fluid exchange system includes successively Connected sealing chamber I 13, horizontal rotation shaft and culture solution circulation channel 11 of the horizontal rotating frame part, sealing chamber III 15, culture solution circulation channel 11 of the longitudinal driven shaft part, culture solution pipe 17 communicating with the culture solution circulation channel , the sealed chamber I 13 is communicated with the external culture solution source, and the culture solution pipe 17 is communicated with the culture chamber 1 through the 3-D motion shaking box 2; the gas exchange system includes the sealed chamber II 14, the horizontal The gas exchange channel 12 of the rotating shaft and the horizontal rotating frame part, the sealed chamber IV 16, the gas exchange channel 12 of the longitudinal rotating shaft part, and the gas pipe 18 communicated with the gas exchange channel 12. The CO gas source is connected, and the air pipe 18 is connected with the culture chamber 1 through the 3-D motion shaking box 2 .
作为本实施例的改进,上述培养液交换系统和气体交换系统可根据需要调整具体经过的通道,选择合适的密封腔I、密封腔II、密封腔III与密封腔IV。As an improvement of this embodiment, the above-mentioned culture fluid exchange system and gas exchange system can adjust the specific passages according to the needs, and select the appropriate sealed chamber I, sealed chamber II, sealed chamber III and sealed chamber IV.
作为本实施例的改进,所述培养室1内均匀间隔设置有多个弹性材料制成的挡板19,可为硅胶等,所述挡板19的头部设置具有圆弧顶部的弹性缓冲薄膜20。在挡板19的作用下,培养物21可作各种不规则运动,模拟更复杂的人体运动,并可以对培养物21形成支承,实现悬浮的生长状态;均匀间隔设置成合适的密度,可模拟母体胎盘中的绒毛膜对培养物21形成保护,可避免对培养物20的伤害,另外,设置具有圆弧顶弹性缓冲薄膜20,可有效减少与培养物21的接触面积,利于与培养基的充分接触,促进其良好的生长。As an improvement of this embodiment, a plurality of baffles 19 made of elastic material are evenly spaced in the culture chamber 1, which can be silica gel, etc., and the head of the baffle 19 is provided with an elastic buffer film with a circular top 20. Under the action of the baffle 19, the culture 21 can perform various irregular movements, simulating more complicated human body movements, and can form a support for the culture 21 to realize a suspended growth state; evenly spaced to a suitable density, can The chorion in the simulated maternal placenta protects the culture 21, which can avoid damage to the culture 20. In addition, the elastic buffer film 20 with a circular arc top can effectively reduce the contact area with the culture 21, which is beneficial to the culture medium. sufficient contact to promote its good growth.
作为本实施例的改进,所述弹性部件为弹簧或橡胶或其它弹性件,本实施例优选弹簧22,可在3-D运动摇箱作用下作简谐振动或摆动,模拟悬吊时的复合运动。As an improvement of this embodiment, the elastic member is a spring or rubber or other elastic members. The preferred spring 22 in this embodiment can perform simple harmonic vibration or swing under the action of the 3-D motion shaker, simulating the compounding during suspension. sports.
作为本实施例的改进,所述培养室1包括室体23和可将室体23密封固定的室盖24,所述室盖24设置有与室体23相互嵌合的卡合结构,所述室体设置有与卡合结构相匹配的卡合配合结构,本实施例的卡合结构为设置在室盖上的凸起25,所述卡合配合结构为与凸起25紧密配合的开口槽26,使用时将培养物装入培养室后,用室盖的凸起装入开口槽26内密封,然后再用螺栓或螺钉或快换机构将两者固定。As an improvement of this embodiment, the culture chamber 1 includes a chamber body 23 and a chamber cover 24 that can seal and fix the chamber body 23. The chamber cover 24 is provided with a snap-fit structure that fits with the chamber body 23. The chamber body is provided with a snap-fit structure that matches the snap-fit structure. The snap-fit structure in this embodiment is a protrusion 25 provided on the chamber cover, and the snap-fit structure is an open groove that closely fits with the protrusion 25 26. After the culture is packed into the cultivation chamber during use, the projection of the chamber cover is used to seal in the opening groove 26, and then the two are fixed with bolts or screws or a quick-change mechanism.
作为本实施例的改进,在所述密封腔I与外界培养液源之间、所述密封腔II与外界37℃5%CO2气源之间均设置有驱动泵27。As an improvement of this embodiment, a drive pump 27 is provided between the sealed chamber I and the external culture solution source, and between the sealed chamber II and the external 37° C. 5% CO 2 gas source.
作为本实施例的改进,还包括用于对本培养装置进行全自动控制的PLC控制系统28和信息显示系统29,有利于对培养过程进行全程监控和管理,提高其培养效率和质量。As an improvement of this embodiment, it also includes a PLC control system 28 and an information display system 29 for fully automatic control of the cultivation device, which is beneficial to monitor and manage the entire cultivation process and improve its cultivation efficiency and quality.
实施例2、采用细胞及器官体外3-D培养装置培养具有器官结构和功能性的人工肝脏的方法Example 2, the method of cultivating an artificial liver with organ structure and functionality using a 3-D culture device for cells and organs in vitro
如图6所示。本实施例使用的装置及试剂盒材料如下:体外细胞及器官3-D培养装置(转速0~50rmp/min的3-D运动摇箱;37℃、5%CO2培养室),条件培养基(CM1,CM2,CM3),100U/mL青霉素,100μg/mL链霉素(Cellgro,cat.no.30-001-CI),5000U/mL青霉素,5000μg/mL链霉素,DMEM/F12(Gibco-BRL,cat.no.11330),VEGF(Pepnotech,cat.no.100-20C),HGF(R&D,cat.no.294-HG-005/CF),bFGF(Pepnotech,cat.no.100-188),牛胰岛素(Sigma,cat.no.I6634),人转铁蛋白(Sigma,cat.no.T1147),左旋甲状腺素(Sigma,cat.no.T6397),亚硒酸钠(Sigma,cat.no.S9133),腐胺(Sigma,cat.no.P5780),孕激素(Sigma,cat.no.7556),Oncostatin M,地塞米松,非必需氨基酸,L-谷氨酰胺。As shown in Figure 6. The device and kit materials used in this embodiment are as follows: in vitro cell and organ 3-D culture device (3-D motion shaker with a rotating speed of 0-50rmp/min; 37°C, 5% CO 2 culture room), conditioned medium (CM1, CM2, CM3), 100U/mL penicillin, 100μg/mL streptomycin (Cellgro, cat.no.30-001-CI), 5000U/mL penicillin, 5000μg/mL streptomycin, DMEM/F12 (Gibco -BRL, cat.no.11330), VEGF (Pepnotech, cat.no.100-20C), HGF (R&D, cat.no.294-HG-005/CF), bFGF (Pepnotech, cat.no.100- 188), bovine insulin (Sigma, cat.no.I6634), human transferrin (Sigma, cat.no.T1147), levothyroxine (Sigma, cat.no.T6397), sodium selenite (Sigma, cat. .no.S9133), putrescine (Sigma, cat.no.P5780), progesterone (Sigma, cat.no.7556), Oncostatin M, dexamethasone, non-essential amino acids, L-glutamine.
制备三种条件培养基(Conditioned mediums,CMs),分别为CM1培养基,CM2培养基,CM3培养基,具体步骤如下:Prepare three conditioned media (Conditioned medias, CMs), respectively CM1 medium, CM2 medium, CM3 medium, the specific steps are as follows:
1)去除胚胎期小鼠肝脏中的干细胞和祖先细胞:1) Depletion of Stem and Progenitor Cells in Embryonic Mouse Liver:
a.解剖显微镜下分别取出7到15天胚胎期小鼠(E7-E15)肝样组织,每期五只胚胎小鼠,混匀后用匀浆器实施缓慢研磨,过滤,收集滤液;a. Under a dissecting microscope, take out the liver-like tissues of embryonic mice (E7-E15) from 7 to 15 days, five embryonic mice in each period, mix them well, grind them slowly with a homogenizer, filter, and collect the filtrate;
b.将滤液在-80℃和39℃条件下反复冻融3次,每次各30mim,然后用0.45μm滤膜过滤,收集滤液;b. Freeze and thaw the filtrate three times under the conditions of -80°C and 39°C, 30mim each time, and then filter with a 0.45μm filter membrane to collect the filtrate;
c.用免疫荧光方法检测过滤液中OX43和OX44阳性造血干细胞、Thy-1阳性肝脏胚胎肝细胞,若检测结果呈阴性,表明胚胎期小鼠肝脏中的干细胞和祖先细胞已去除;c. Detect OX43 and OX44 positive hematopoietic stem cells and Thy-1 positive liver embryonic liver cells in the filtrate by immunofluorescence method. If the test result is negative, it shows that the stem cells and progenitor cells in the liver of the embryonic mouse have been removed;
2)采用蛋白试剂盒检测蛋白含量(50-100mg/mL)2) Use a protein kit to detect protein content (50-100mg/mL)
3)配制CM1,CM2和CM3培养基3) Prepare CM1, CM2 and CM3 medium
CM1培养基:向去除干细胞和祖先细胞的胚胎期小鼠肝脏滤液和DMEM完全培养液的混合溶液(1:4)中加入VEGF至VEGF终浓度为20ng/ml;CM1 medium: add VEGF to the mixed solution (1:4) of embryonic mouse liver filtrate and DMEM complete culture solution (1:4) from which stem cells and progenitor cells have been removed to a final concentration of VEGF of 20ng/ml;
CM2培养基:向去除干细胞和祖先细胞的胚胎期小鼠肝脏滤液和DMEM完全培养液的混合溶液(1:4)中加入HGF、bFGF,牛胰岛素、人转铁蛋白、左旋甲状腺素、亚硒酸钠、腐胺、孕激素至HGF终浓度为10ng/mL,bFGF终浓度为5ng/mL,牛胰岛素终浓度为0.5mg/mL,人转铁蛋白终浓度为0.5mg/mL,左旋甲状腺素终浓度为40ug/mL,亚硒酸钠终浓度为34ug/mL,腐胺终浓度为0.5ug/mL,孕激素终浓度为6ug/mL(各组分浓度为多少,请补充);CM2 medium: Add HGF, bFGF, bovine insulin, human transferrin, levothyroxine, and selenite to a mixed solution (1:4) of embryonic mouse liver filtrate and DMEM complete culture medium from which stem cells and progenitor cells have been removed Sodium phosphate, putrescine, progesterone until the final concentration of HGF is 10ng/mL, the final concentration of bFGF is 5ng/mL, the final concentration of bovine insulin is 0.5mg/mL, the final concentration of human transferrin is 0.5mg/mL, and the final concentration of levothyroxine The final concentration is 40ug/mL, the final concentration of sodium selenite is 34ug/mL, the final concentration of putrescine is 0.5ug/mL, and the final concentration of progesterone is 6ug/mL (please add the concentration of each component);
CM3培养基:向去除干细胞和祖先细胞的胚胎期小鼠肝脏滤液和DMEM完全培养液的混合溶液(1:4)中加入HGF、bFGF,Oncostatin M、地塞米松、非必需氨基酸和L-谷氨酰胺至HGF终浓度为100ng/mL,bFGF终浓度为50ng/mL,Oncostatin M终浓度为20ng/ml,地塞米松终浓度为0.1μM,非必需氨基酸质量分数为1%和L-谷氨酰胺终浓度为5mM。CM3 medium: add HGF, bFGF, Oncostatin M, dexamethasone, non-essential amino acids, and L-glucose to a mixed solution (1:4) of embryonic mouse liver filtrate and DMEM complete culture medium from which stem cells and progenitor cells have been removed Aminoamide to a final concentration of HGF of 100 ng/mL, a final concentration of bFGF of 50 ng/mL, a final concentration of Oncostatin M of 20 ng/ml, a final concentration of dexamethasone of 0.1 μM, a mass fraction of non-essential amino acids of 1% and L-glutamine The final amide concentration was 5 mM.
然后利用配制的CM1,CM2和CM3培养基体外3-D培养具有器官结构和功能性的人工肝脏,具体方法如下:Then use the prepared CM1, CM2 and CM3 medium to culture in vitro 3-D artificial liver with organ structure and function, the specific method is as follows:
首先在计算机系统监控下,利用三步法分别从门静脉和下腔静脉将细胞包括种子干细胞缓慢注入支架中,每次至少3~5×105,间隔15-30min,注射2-3次;然后将注入种子干细胞的WDLS(以下称为WDLS-NG2+HSC)放入培养室中,并将培养室弹性地悬挂于3-D运动摇箱内,启动培养液交换系统和气体交换系统,加入500μl CM1培养基进行体外3-D培养一周(第1~7天),白天启动水平旋转机构,先水平向左360°旋转8h,后水平向右360°旋转8h,晚上启动纵向旋转机构和水平旋转机构,进行纵向和水平旋转相结合的复合3-D旋转8h,每两天补加200μL CM1培养基;培养进入第二周后(第8天),改换500μLCM2培养基,培养方式及条件与第一周相同(第8-14天);培养进入第三周后(第15天),改换500μL CM3培养基,培养方式及条件与第一周相同,剂量与方式与第一周相同,持续7天(8-14天);培养进入第三周后(第15天),改换500μL CM3培养基,剂量与方式与第一周相同(第15~21天),培养21天后终止培养,获得具有器官结构和功能性的人工肝脏,然后于白光和荧光显微镜下观察组织学结构,并分析上清肝脏功能蛋白。结果显示,培养至第9天形成了肝叶样轮廓(图6A),培养至第21天形成了全肝样轮廓(图6B),对21天的培养物进行H&E染色和培养物上清功能蛋白分析,显示培养物具有与正常肝组织(图6Ca)类似结构(图6Cb)如有肝小叶中央静脉(thecentral vein,CV)形成(箭头所示),随着培养时间的延长,培养物上清功能蛋白(Alb表示肝脏白蛋白)分泌增加(图6Cc),表明种子干细胞在特定培养微环境中可形成具有器官结构和功能的人工肝脏,表现了很有临床应用潜力的种子细胞。First, under the monitoring of the computer system, slowly inject cells including seeded stem cells into the scaffold from the portal vein and inferior vena cava using a three-step method, at least 3-5×10 5 each time, 2-3 times at intervals of 15-30 minutes; then Put the WDLS injected with seed stem cells (hereinafter referred to as WDLS-NG2 + HSC) into the culture chamber, and hang the culture chamber elastically in the 3-D motion shaker, start the culture fluid exchange system and gas exchange system, and add 500 μl 3-D culture in vitro with CM1 medium for one week (1st to 7th day), start the horizontal rotation mechanism during the day, first rotate 360° to the left horizontally for 8 hours, then rotate 360° to the right horizontally for 8 hours, and start the vertical rotation mechanism and horizontal rotation at night Institutions, combined vertical and horizontal rotation combined 3-D rotation for 8 hours, supplemented with 200 μL CM1 medium every two days; after the second week of culture (8th day), replaced 500 μL CM2 medium, and the culture method and conditions were the same as the first The same for one week (day 8-14); after the third week of culture (day 15), replace 500 μL CM3 medium, the culture method and condition are the same as the first week, the dosage and method are the same as the first week, and last for 7 days. days (8-14 days); after the third week of culture (day 15), replace 500 μL of CM3 medium with the same dose and method as the first week (days 15-21), and terminate the culture after 21 days of culture to obtain Organ structure and function of the artificial liver, and then observe the histological structure under white light and fluorescence microscopes, and analyze the supernatant liver functional proteins. The results showed that a lobe-like outline of the liver was formed by day 9 (Figure 6A), and a whole liver-like outline was formed by day 21 (Figure 6B), H&E staining and culture supernatant functional Protein analysis showed that the culture had a structure similar to that of normal liver tissue (Fig. 6Ca) (Fig. 6Cb). If the central vein (the central vein, CV) of the hepatic lobule was formed (indicated by the arrow), with the prolongation of the culture time, the culture on the The secretion of serum albumin (Alb means hepatic albumin) increased (Fig. 6Cc), indicating that the seed stem cells can form an artificial liver with organ structure and function in a specific culture microenvironment, showing the seed cells with great potential for clinical application.
最后说明两点:(1)我们研制的三种条件培养基(CM1、CM2、CM3—)的制备是根据哺乳类动物肝脏发育成熟的理论基础(见图7),花费了大量时间进行科学研究证明而获得的,相关文章即将发表;(2)以上优选实施例仅用以说明本发明的技术方案而非限制,尽管通过上述优选实施例已经对本发明进行了详细的描述,但本领域技术人员应当理解,可以在形式上和细节上对其作出各种各样的改变,而不偏离本发明权利要求书所限定的范围。Finally, two points are explained: (1) The preparation of the three conditional media (CM1, CM2, CM3—) we developed is based on the theoretical basis of mammalian liver development and maturation (see Figure 7), and a lot of time has been spent on scientific research Obtained by proof, relevant articles will be published soon; (2) the above preferred embodiments are only used to illustrate the technical solutions of the present invention and not to limit, although the present invention has been described in detail by the above preferred embodiments, those skilled in the art It should be understood that various changes in form and details may be made therein without departing from the scope of the invention defined by the appended claims.
Claims (12)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510346955.7A CN104911104B (en) | 2015-06-23 | 2015-06-23 | In-vitro cell and organ 3-D culture device and artificial organ culture method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510346955.7A CN104911104B (en) | 2015-06-23 | 2015-06-23 | In-vitro cell and organ 3-D culture device and artificial organ culture method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104911104A CN104911104A (en) | 2015-09-16 |
| CN104911104B true CN104911104B (en) | 2017-04-12 |
Family
ID=54080551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510346955.7A Expired - Fee Related CN104911104B (en) | 2015-06-23 | 2015-06-23 | In-vitro cell and organ 3-D culture device and artificial organ culture method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104911104B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106754356B (en) * | 2016-11-30 | 2019-07-23 | 广州迈普再生医学科技股份有限公司 | Three-dimensional perfused culture system and the histoorgan of 3D printing |
| CN117821249B (en) * | 2024-01-09 | 2024-10-29 | 中国人民解放军空军军医大学 | Respiratory alternating force dynamic cell culture system and culture method |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2106834U (en) * | 1991-11-06 | 1992-06-10 | 刘新利 | Tissue cultuer bottle |
| JP2003070464A (en) * | 2001-09-04 | 2003-03-11 | Mitsubishi Heavy Ind Ltd | Method for culturing cell, method for producing artificial organ and the resultant artificial organ |
| WO2004061092A1 (en) * | 2002-12-27 | 2004-07-22 | Mitsubishi Heavy Industries, Ltd. | Method of culturing pluripotent stem cells and culture apparatus therefor |
| JP4817362B2 (en) * | 2003-08-19 | 2011-11-16 | 独立行政法人国立循環器病研究センター | Apparatus and method for uniform cell seeding on a substrate having a three-dimensional surface |
| GB0520021D0 (en) * | 2005-10-01 | 2005-11-09 | Univ Liverpool | A reactor |
| CN102086438B (en) * | 2009-12-07 | 2012-12-19 | 韩春茂 | Device and method for biological culture of cell or tissue engineering |
| CN102876573B (en) * | 2012-10-26 | 2013-11-20 | 黑龙江八一农垦大学 | Mammal embryo in-vitro culture device and culture method thereof |
| CN104611225A (en) * | 2015-02-16 | 2015-05-13 | 昆明市第一人民医院 | Bioreactor for constructing tissue engineering liver by using in-vitro circulatory perfusion |
| CN104694390B (en) * | 2015-03-17 | 2016-08-24 | 天津开发区合普工贸有限公司 | A kind of equilibrium shift experiments Embryo Gallus domesticus cultivates instrument automatically |
| CN204714823U (en) * | 2015-06-23 | 2015-10-21 | 中国人民解放军第三军医大学第一附属医院 | Cell and the external 3-D culture apparatus of organ |
-
2015
- 2015-06-23 CN CN201510346955.7A patent/CN104911104B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN104911104A (en) | 2015-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wu et al. | Recent advances in three‐dimensional stem cell culture systems and applications | |
| Stephenson et al. | Recent advances in bioreactors for cell-based therapies | |
| Kumar et al. | Large scale industrialized cell expansion: producing the critical raw material for biofabrication processes | |
| Lazar et al. | Formation of porcine hepatocyte spheroids for use in a bioartificial liver | |
| Sumbal et al. | Mammary organoids and 3D cell cultures: old dogs with new tricks | |
| CN103194390B (en) | Double-loop oscillation perfusion-type biological reaction system | |
| Gelinsky et al. | Bioreactors in tissue engineering: Advances in stem cell culture and three‐dimensional tissue constructs | |
| Song et al. | Numerical simulation of fluid field and in vitro three-dimensional fabrication of tissue-engineered bones in a rotating bioreactor and in vivo implantation for repairing segmental bone defects | |
| Jia et al. | Preparation and characterization of polylactic acid/nano hydroxyapatite/nano hydroxyapatite/human acellular amniotic membrane (PLA/nHAp/HAAM) hybrid scaffold for bone tissue defect repair | |
| JP2014519309A (en) | Bioreactor with lid for easy access to incubation cavity | |
| CN104911104B (en) | In-vitro cell and organ 3-D culture device and artificial organ culture method | |
| JPWO2005014774A1 (en) | Animal cell culture carrier, animal cell culture method and transplantation method using the culture carrier | |
| Naing et al. | Three-dimensional culture and bioreactors for cellular therapies | |
| CN103497892B (en) | A kind of cell cultures base material and its preparation method and application | |
| WO2024251234A1 (en) | Serum-free culture medium for mesenchymal stem cells and use thereof | |
| Beken et al. | Collagen-gel cultures of rat hepatocytes: collagen-gel sandwich and immobilization cultures | |
| CN204714823U (en) | Cell and the external 3-D culture apparatus of organ | |
| Zhang et al. | Bioreactor technology for cell therapy manufacturing in regenerative medicine | |
| Chen et al. | Facile suspension culture protocol of the liver biliary organoids | |
| US20200239824A1 (en) | Hydrogel for stem cell and organoid culture | |
| Santos et al. | Scaling-up ex vivo expansion of mesenchymal stem/stromal cells for cellular therapies | |
| CN101130752B (en) | Culture method of applying load evenly and bioreactor | |
| Kreß et al. | Application of scaffold-free 3D models | |
| US20250101359A1 (en) | 3d hydrogel system for cell scale-up and bioproduction | |
| Bijan Nejad et al. | Investigation of the role of alginate containing high guluronic acid on osteogenic differentiation capacity of human umbilical cord Wharton’s jelly mesenchymal stem cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170412 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |